Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Gastric or Gastroesophageal Cancer × bemarituzumab × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Stomach Neoplasms 6 Urinary Bladder Neoplasms 2 Adenocarcinoma 2 Uterine Cervical Neoplasms 1 Squamous-Cell Non-Small-Cell Lung Cancer 1 Ovarian Neoplasms 1 Gastrointestinal Neoplasms 1 Gastric or Gastroesophageal Cancer 1 Esophageal Neoplasms 1 Endometrial Neoplasms 1 Carcinoma, Renal Cell 1

Interventions

bemarituzumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05913115 2023-06-22

A Study Evaluating Safety and Pharmacokinetics of FPA144 in Japanese Patients With Advanced Gastric or Gastroesophageal Cancer

Amgen

Phase 1 Completed

Gastrointestinal

Gastric or Gastroesophageal Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡